Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natalie Pelusi"'
Autor:
Laura K. Esser, Vittorio Branchi, Sonia Leonardelli, Natalie Pelusi, Adrian G. Simon, Niklas Klümper, Jörg Ellinger, Stefan Hauser, Maria A. Gonzalez-Carmona, Manuel Ritter, Glen Kristiansen, Hubert Schorle, Michael Hölzel, Marieta I. Toma
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer accounting for 80% of all renal cancers as well as the majority of renal cancer-associated deaths. During the last decade, the treatment paradigm for ccRCC has radically changed.
Externí odkaz:
https://doaj.org/article/97d1d568f6ac4813aad29aec50665885
Publikováno v:
Virchows Archiv.
Inflammatory fibroid polyps (IFP) are rare and benign mesenchymal tumours of the gastrointestinal tract. They are submucosal spindle cell lesions with an eosinophilic-rich inflammatory infiltrate and mutations in the platelet-derived growth factor re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01988be2938a32f3f0307f51d1e29b64
https://doi.org/10.1007/s00428-023-03557-y
https://doi.org/10.1007/s00428-023-03557-y
Autor:
C. Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I. Gaidzik, Hanno Glimm, Ulrich T. Hacker, Volker Heinemann, Anna L. Illert, Ulrich Keilholz, Thomas Kindler, Martin Kirschner, Bastian Schilling, Jens T. Siveke, Thomas Schroeder, Verena Tischler, Sebastian Wagner, Wilko Weichert, Daniel Zips, Sonja Loges, Ralf Bargou (Würzburg), Hendrik Bläker (Leipzig), Melanie Börries (Freiburg), Christian Brandts (Frankfurt), Nikolas von Bubnoff (Lübeck), Melanie Demes (Frankfurt), Alexander Desuki (Mainz), Hartmut Döhner (Ulm), Justus Duyster (Freiburg), Nadine Gaisa (Aachen), Annkristin Heine (Bonn), Christoph Heining (Dresden), Peter Horak (Heidelberg), Ivan Jelas (Berlin), Philipp J. Jost (München), Andreas Jung (München), Thomas Kirchner (München), Frederick Klauschen (Berlin), Simon Kreutzfeldt (Heidelberg), Jörg Kumbrink (München), Volker Kunzmann (Würzburg), Silke Lassmann (Freiburg), Klaus Metzeler (München), Peter Möller (Ulm), Nadina Ortiz-Brüchle (Aachen), Claudia Paret (Mainz), Natalie Pelusi (Bonn), Christoph Peters (Freiburg), Nicole Pfarr (München), Daniela Richter (Dresden), Kristina Riedmann (München), Damian Rieke (Berlin), Christoph Ritzel (Mainz), Dirk Schadendorf (Essen), Hans-Ulrich Schildhaus (Essen), Hubert Schorle (Bonn), Thomas Seufferlein (Ulm), Ronald Simon (Hamburg), Albrecht Stenzinger (Heidelberg), Ghazaleh Tabatabai (Tübingen), Janna-Lisa Velthaus (Hamburg), Martin Werner (Freiburg), Peter J. Wild (Frankfurt), Jürgen Wolf (Köln)
Publikováno v:
European Journal of Cancer. 135:1-7
Precision cancer medicine (PCM) holds great promises to offer more effective therapies to patients based on molecular profiling of their individual tumours. Although the PCM approach seems intuitive, multiple conceptional and structural challenges in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff4f13555d75c8a8b4729bce310670e
https://doi.org/10.1016/j.ejca.2020.04.019
https://doi.org/10.1016/j.ejca.2020.04.019
Autor:
C. Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I. Gaidzik, Hanno Glimm, Ulrich T. Hacker, Volker Heinemann, Anna L. Illert, Ulrich Keilholz, Thomas Kindler, Martin Kirschner, Bastian Schilling, Jens T. Siveke, Thomas Schroeder, Verena Tischler, Sebastian Wagner, Wilko Weichert, Daniel Zips, Sonja Loges, Ralf Bargou (Würzburg), Hendrik Bläker (Leipzig), Melanie Börries (Freiburg), Christian Brandts (Frankfurt), Nikolas von Bubnoff (Freiburg), Melanie Demes (Frankfurt), Alexander Desuki (Mainz), Hartmut Döhner (Ulm), Justus Duyster (Freiburg), Nadine Gaisa (Aachen), Annkristin Heine (Bonn), Christoph Heining (Dresden), Peter Horak (Heidelberg), Ivan Jelas (Berlin), Philipp J. Jost (München), Andreas Jung (München), Thomas Kirchner (München), Frederick Klauschen (Berlin), Simon Kreutzfeldt (Heidelberg), Jörg Kumbrink (München), Volker Kunzmann (Würzburg), Silke Lassmann (Freiburg), Klaus Metzeler (München), Peter Möller (Ulm), Nadina Ortiz-Brüchle (Aachen), Claudia Paret (Mainz), Natalie Pelusi (Bonn), Christoph Peters (Freiburg), Nicole Pfarr (München), Daniela Richter (Dresden), Kristina Riedmann (München), Damian Rieke (Berlin), Christoph Ritzel (Mainz), Dirk Schadendorf (Essen), Hans-Ulrich Schildhaus (Essen), Hubert Schorle (Bonn), Thomas Seufferlein (Ulm), Ronald Simon (Hamburg), Albrecht Stenzinger (Heidelberg), Ghazaleh Tabatabai (Tübingen), Janna-Lisa Velthaus (Hamburg), Martin Werner (Freiburg), Peter J. Wild (Frankfurt), Jürgen Wolf (Köln)
Publikováno v:
European Journal of Cancer. 162:245-246
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bde745959fddd05b69fde9954d0a435
https://doi.org/10.1016/j.ejca.2021.11.014
https://doi.org/10.1016/j.ejca.2021.11.014
Autor:
Giancarlo Troncone, Carlos E. de Andrea, Francesco Pepe, Giovanni Tallini, Maria D. Lozano, Paul Hofman, Verena Tischler, Natalie Pelusi, Roberta Sgariglia, Sabine Merkelbach-Bruse, Pasquale Pisapia, Sara Vander Borght, Janna Siemanowski, Daniela Cabibi, Marta Castiglia, Javier Freire, Dario de Biase, Spasenija Savic, Gabriella Fontanini, Antonio Russo, Reinhard Büttner, Lukas Bubendorf, Birgit Weynand, Catherine I. Dumur, Marius Ilie, Umberto Malapelle, Tom Xu, Roberto Pappesch, Michel Bilh, Valerio Gristina, Gianluca Roma, Massimo Barberis, Mariantonia Nacchio
AimNext generation sequencing (NGS) represents a key diagnostic tool to identify clinically relevant gene alterations for treatment-decision making in cancer care. However, the complex manual workflow required for NGS has limited its implementation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d13aabc2f97bf3e41eede2cd463cf6
http://hdl.handle.net/11585/839899
http://hdl.handle.net/11585/839899
Autor:
Maria A. Gonzalez-Carmona, Manuel Ritter, Sonia Leonardelli, Adrian Georg Simon, Glen Kristiansen, Jörg Ellinger, Vittorio Branchi, Niklas Klümper, Laura Esser, Natalie Pelusi, Michael Hölzel, Marieta Toma, Stefan Hauser, Hubert Schorle
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer accounting for 80% of all renal cancers as well as the majority of renal cancer-associated deaths. During the last decade, the treatment paradigm for ccRCC has radically changed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a6a333b14f7d0f71bb00fb0f408326
https://doi.org/10.3389/fonc.2020.01775
https://doi.org/10.3389/fonc.2020.01775
Autor:
Neha Sharma, Natalie Pelusi, Caroline Kubaczka, Hubert Schorle, Franziska Kaiser, Julia Hartweg, Dominik Nitsche, Selina Jansky, Jan Langkabel
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 15
International Journal of Molecular Sciences, Vol 21, Iss 5503, p 5503 (2020)
Volume 21
Issue 15
International Journal of Molecular Sciences, Vol 21, Iss 5503, p 5503 (2020)
Activating mutations in the human KIT receptor is known to drive severe hematopoietic disorders and tumor formation spanning various entities. The most common mutation is the substitution of aspartic acid at position 816 to valine (D816V), rendering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd097e12954e3f1a24e7a4e57ce2363c
http://europepmc.org/articles/PMC7432075
http://europepmc.org/articles/PMC7432075
Autor:
Maike Kosanke, Viktor Janzen, Tamara Riedt, Jin Li, Ines Gütgemann, Corinna Rösseler, Hubert Schorle, Natalie Pelusi, Kristin Seré, Martin Zenke
Publikováno v:
Scientific reports 7, 41427 (2017). doi:10.1038/srep41427
Scientific reports 7, 41427 (2017). doi:10.1038/srep41427
Published by Nature Publishing Group, London
Published by Nature Publishing Group, London
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::239115e34a3f8792d48c91113e551114
Autor:
Natalie, Pelusi, Maike, Kosanke, Tamara, Riedt, Corinna, Rösseler, Kristin, Seré, Jin, Li, Ines, Gütgemann, Martin, Zenke, Viktor, Janzen, Hubert, Schorle
Publikováno v:
Scientific Reports
Activating mutations leading to ligand-independent signaling of the stem cell factor receptor KIT are associated with several hematopoietic malignancies. One of the most common alterations is the D816V mutation. In this study, we characterized mice,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd8241fba095e631f83ad24ea2afb0ae
https://pubmed.ncbi.nlm.nih.gov/28128288
https://pubmed.ncbi.nlm.nih.gov/28128288
Publikováno v:
Virchows Archiv: European Journal of Pathology; Oct2023, Vol. 483 Issue 4, p535-539, 5p